Natera (San Carlos, CA) is a genomic diagnostics company offering advanced prenatal testing. The company is focused on technology to deliver improved accuracy and reliability in preconception and prenatal genetic testing services. The company offers a range of tests, from pre-implantation genetic diagnosis (PGD) for in-vitro fertilization (IVF) to advances in the field of non-invasive prenatal testing (NIPT).
The LTP Value Add
IPO in 2015
Previous Partner Companies
Transformation Capital Team
COVID-19 and our Partner Companies
Transforming healthcare and offering solutions to combat the COVID-19 outbreak